A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-0162PMID 15958572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.

  2004cited by this paper
• BCL-2 in prostate cancer: A minireview

  2004cited by this paper
• Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence

  2004cited by this paper
• Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy.

  2004cited by this paper
• NE-10 Neuroendocrine Cancer Promotes the LNCaP Xenograft Growth in Castrated Mice

  2004cited by this paper
• Regulation of Apoptosis in Prostate Cancer

  2004cited by this paper
• Contribution of the Androgen Receptor to Prostate Cancer Predisposition and Progression

  2004cited by this paper
• Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone.

  2003cited by this paper
• Androgen receptors in prostate cancer.

  2003cited by this paper
• You Wnt some, you lose some: oncogenes in the Wnt signaling pathway.

  2003cited by this paper
• Protocadherin X (PCDHX) and Y (PCDHY) genes; multiple mRNA isoforms encoding variant signal peptides and cytoplasmic domains

  2003cited by this paper
• NF‐κB nuclear localization and its prognostic significance in prostate cancer

  2003cited by this paper
• Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.

  2003cited by this paper
• The Wnt signaling pathway and its role in tumor development

  2003cited by this paper
• The androgen receptor in hormone-refractory prostate cancer: relevance of different mechanisms of androgen receptor signaling (Review).

  2003cited by this paper
• NF-kappa B nuclear localization and its prognostic significance in prostate cancer.

  2003cited by this paper
• β-Catenin-related Anomalies in Apoptosis-resistant and Hormone-refractory Prostate Cancer Cells

  2003cited by this paper
• Wnt signaling promotes oncogenic transformation by inhibiting c-Myc–induced apoptosis

  2002cited by this paper
• Wnt signaling: a complex issue.

  2002cited by this paper
• Androgen receptors in prostate cancer.

  2002cited by this paper
• Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.

  2002cited by this paper
• In vitro evidence for complex modes of nuclear β-catenin signaling during prostate growth and tumorigenesis

  2002cited by this paper
• Hormonal therapy of prostate cancer.

  2002cited by this paper
• Acquired neuroendocrine-positivity during maximal androgen blockade in prostate cancer patients.

  2002cited by this paper
• The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells

  2002influential reference
• Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.

  2002cited by this paper
• Prognostic significance of neuroendocrine differentiation, proliferation activity and androgen receptor expression in prostate cancer

  2001cited by this paper
• COX-2 Specific Inhibitor, NS-398, Increases Macrophage Migration Inhibitory Factor Expression and Induces Neuroendocrine Differentiation in C4-2b Prostate Cancer Cells

  2001cited by this paper
• Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma.

  2001cited by this paper
• Interleukin-6- and Cyclic AMP-Mediated Signaling Potentiates Neuroendocrine Differentiation of LNCaP Prostate Tumor Cells

  2001cited by this paper
• Up-regulation of neuroendocrine differentiation in prostate cancer after androgen deprivation therapy, degree and androgen independence.

  2001cited by this paper
• Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.

  2001cited by this paper
• WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription

  2001cited by this paper
• Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

  2001cited by this paper
• Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.

  2000cited by this paper
• Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate.

  2000cited by this paper
• Neuroendocrine differentiation is not prognostic of failure after radical prostatectomy but correlates with tumor volume.

  2000cited by this paper
• Detection and analysis of β‐catenin mutations in prostate cancer

  2000cited by this paper
• Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain

  2000cited by this paper
• Detection and analysis of beta-catenin mutations in prostate cancer.

  2000cited by this paper
• Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression.

  2000cited by this paper
• Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

  1999cited by this paper
• From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells.

  1999cited by this paper
• β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

  1999cited by this paper
• Beta-catenin mutations in human prostate cancer.

  1998cited by this paper
• β-Catenin Mutations in Human Prostate Cancer

  1998cited by this paper
• Differential Effects of Neuroactive Steroids on Somatostatin and Dopamine Secretion from Primary Hypothalamic Cell Cultures

  1997cited by this paper
• Neuroendocrine differentiation and prognosis in prostatic adenocarcinoma.

  1997cited by this paper
• Histologic variants of adenocarcinoma and other carcinomas of prostate: pathologic criteria and clinical significance.

  1997cited by this paper
• Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone-depleted medium.

  1997cited by this paper
• Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

  1996cited by this paper
• Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy.

  1996cited by this paper
• Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.

  1995cited by this paper
• Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP.

  1994cited by this paper
• The neuroendocrine cell population of the human prostate gland.

  1993cited by this paper
• Neuroendocrine differentiation in human prostatic carcinoma.

  1992cited by this paper
• Neuroendocrine differentiation in human prostatic carcinoma

  1992cited by this paper
• Cáncer

  1939cited by this paper

• Co-modulation of a circular form of PCDH11Y during neuroendocrine differentiation of prostate cancer

  2025cites this paper
• A Novel Prognostic Risk‐Scoring Model Based on RAS Gene‐Associated Cluster in Pediatric Acute Myeloid Leukemia

  2025cites this paper
• The dual role of PCDH9 in tumors, neurological and developmental diseases

  2025cites this paper
• 基于生物信息学分析探索PCDHGB4在肺鳞癌发生中的作用

  2024cites this paper
• Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer

  2023cites this paper
• Protein Repeats Show Clade-Specific Volatility in Aves

  2023cites this paper
• Targeting Prostate Cancer, the ‘Tousled Way’

  2023cites this paper
• DNA methylation alterations at RE1-silencing transcription factor binding sites and their flanking regions in cancer

  2023cites this paper
• Comparative Proteomics of the Acanthopagrus schlegelii Gonad in Different Sex Reversal

  2022cites this paper
• Association between clinical variations and copy number variations in cases with Turner syndrome

  2022cites this paper
• Protocadherin B9 Is Associated with Human Esophageal Squamous Cell Carcinoma Progression

  2022cites this paper
• Molecular mechanisms of neuroendocrine differentiation in prostate cancer progression

  2022cites this paper
• Identification of Biomarkers Associated with Liver Metastasis Progression from Colorectal Cancer Using Exosomal RNA Profiling

  2022cites this paper
• Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation

  2022cites this paper
• A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer

  2021cites this paper
• Loss and revival of androgen receptor signaling in advanced prostate cancer

  2021cites this paper
• Genomic and transcriptomic characterization of the human glioblastoma cell line AHOL1.

  2021cites this paper
• Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer

  2021cites this paper
• Mechanisms of castration resistant prostate cancer formation and progression through neuroendocrine differentiation

  2021cites this paper
• CD103 Deficiency Promotes Autism (ASD) and Attention-Deficit Hyperactivity Disorder (ADHD) Behavioral Spectra and Reduces Age-Related Cognitive Decline

  2020cites this paper
• A Novel Research Area of PCDH-PC in Inhibition of Prostate Cancer Cells Invasion and Metastasis through Epithelial: Mesenchymal Transition

  2020cites this paper
• The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer

  2020cites this paper
• Protocadherins at the Crossroad of Signaling Pathways

  2020cites this paper
• The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer

  2019cites this paper
• Wnt/Beta-Catenin Signaling and Prostate Cancer Therapy Resistance.

  2019cites this paper
• The epigenetic and transcriptional landscape of neuroendocrine prostate cancer.

  2019cites this paper
• Targeting FAT1 Inhibits Carcinogenesis, Induces Oxidative Stress and Enhances Cisplatin Sensitivity through Deregulation of LRP5/WNT2/GSS Signaling Axis in Oral Squamous Cell Carcinoma

  2019cites this paper
• Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer

  2019cites this paper
• Genomic and Transcriptomic Characterization of the New Human Glioblastoma Cell Line AHOL1

  2019cites this paper
• The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells

  2019cites this paper
• Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2

  2019cites this paper
• PCDH10 inhibits invasion of lymphoma cells by regulating β-catenin.

  2019cites this paper
• Wnt activator FOXB2 drives prostate cancer neuroendocrine differentiation

  2019cites this paper
• Prostate cancer susceptibility gene HIST1H1A is a modulator of androgen receptor signaling and epithelial to mesenchymal transition

  2018cites this paper
• Modulation of Mutant KrasG12D-Driven Lung Tumorigenesis In Vivo by Gain or Loss of PCDH7 Function

  2018cites this paper
• EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers.

  2018cites this paper
• Modulation of mutant KrasG12D-driven lung tumorigenesis in vivo by gain or loss of PCDH7 function

  2018cites this paper
• Decoding Somatic Driver Gene Mutations and Affected Signaling Pathways in Human Medulloblastoma Subgroups

  2018cites this paper
• Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer

  2018cites this paper
• Androgen receptor suppresses prostate cancer cell invasion via altering the miR-4496/β-catenin signals.

  2018cites this paper
• MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells

  2018influential citation
• Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients

  2018cites this paper
• Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories

  2017cites this paper
• Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications

  2017cites this paper
• Epigenetic silencing of protocadherin 10 in colorectal cancer.

  2017cites this paper
• Blocking the Feedback Loop between Neuroendocrine Differentiation and Macrophages Improves the Therapeutic Effects of Enzalutamide (MDV3100) on Prostate Cancer

  2017cites this paper
• Expression of protocadherin 11Yb (PCDH11Yb) in seminal germ cells is correlated with fertility status in men.

  2017cites this paper
• Regulation of Wnt signaling by protocadherins.

  2017cites this paper
• Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up‐regulation of IRF1

  2017cites this paper
• PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis.

  2017cites this paper
• Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression

  2016cites this paper
• Neuronal Trans‐Differentiation in Prostate Cancer Cells

  2016cites this paper
• Aberrant expression and functions of protocadherins in human malignant tumors

  2016cites this paper
• The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells

  2015cites this paper
• Co regulation of srGAP1 by Wnt and androgen receptor signaling: a new target for treatment of CRPC

  2015cites this paper
• PCDH10 inhibits cell proliferation of multiple myeloma via the negative regulation of the Wnt/β-catenin/BCL-9 signaling pathway.

  2015cites this paper
• Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives

  2015cites this paper
• PCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt/β-catenin signalling pathway in hepatocellular carcinoma

  2014cites this paper
• Beyond E-cadherin: roles of other cadherin superfamily members in cancer

  2014cites this paper
• Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells

  2014cites this paper
• The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression

  2014cites this paper
• Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC

  2014cites this paper
• The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells

  2014cites this paper
• Wnt signaling in castration-resistant prostate cancer: implications for therapy.

  2014cites this paper
• AWARD NUMBER: W81XWH-13-1-0257 TITLE: Coregulation of srGAP1 by Wnt and Androgen Receptor Signaling: A New Target for Treatment of CRPC

  2014cites this paper
• Transcriptional activity of c-Jun is critical for the suppression of AR function.

  2013influential citation
• Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.

  2013cites this paper
• Circulating Tumour Cells and Biomarkers in Neuroendocrine Tumours

  2013cites this paper
• Protocadherin 11X/Y a Human-Specific Gene Pair: an Immunohistochemical Survey of Fetal and Adult Brains

  2012cites this paper
• Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β‐catenin signaling in prostate cancer cells

  2012cites this paper
• Wnt11 in 2011 – the regulation and function of a non‐canonical Wnt

  2012cites this paper
• Clinical and antibacterial effect of an anti-inflammatory toothpaste formulation with Scutellaria baicalensis extract on experimental gingivitis

  2011cites this paper
• Prostate Cancer Progression to Androgen Independent Disease: The Role of the Wnt/β-Catenin Pathway

  2011cites this paper
• Comparative proteomics analysis of midgut samples from Takifugu rubripes exposed to excessive fluoride: initial molecular response to fluorosis

  2011cites this paper
• Roles of androgen receptor and Wnt signaling pathway in prostate cancer.

  2010cites this paper
• Molecular genetics of epilepsy and mental retardation limited to females (EFMR).

  2010cites this paper
• Wnt/β-Catenin activation promotes prostate tumor progression in a mouse model

  2010cites this paper
• Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer

  2010cites this paper
• Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells

  2010cites this paper
• The protocadherin 11X/Y gene pair as a putative determinant of cerebral dominance in Homo sapiens

  2009cites this paper
• Involvement of members of the cadherin superfamily in cancer.

  2009cites this paper
• An Exon-Based Comparative Variant Analysis Pipeline to Study the Scale and Role of Frameshift and Nonsense Mutation in the Human-Chimpanzee Divergence

  2009cites this paper
• Neuroendocrine differentiation in prostate cancer.

  2009cites this paper
• (Leave blank) Award Number: W81XWH-08-1-0394 TITLE: Interplay of CREB and ATF2 in ionizing radiation-induced neuroendocrine differentiation of prostate cancer cells

  2009cites this paper
• Sphingosine Kinase-1 Is Central to Androgen-Regulated Prostate Cancer Growth and Survival

  2009cites this paper
• Cellular and molecular signatures of androgen ablation of prostate cancer

  2009cites this paper
• Evidence for positive selection on Protocadherin Y gene in Homo sapiens: implications for schizophrenia.

  2009cites this paper
• Junctional music that the nucleus hears: cell-cell contact signaling and the modulation of gene activity.

  2009cites this paper
• Gene expression profiles of thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome reveal novel molecular mechanism.

  2009cites this paper
• Frequent Long-Range Epigenetic Silencing of Protocadherin Gene Clusters on Chromosome 5q31 in Wilms' Tumor

  2009cites this paper
• E-cadherin/Catenin Complex Status in Solid Pseudopapillary Tumor of the Pancreas

  2008cites this paper
• Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase.

  2008influential citation
• Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression.

  2008cites this paper
• Neuroendocrine differentiation in prostate cancer

  2008cites this paper
• Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanism.

  2008cites this paper
• Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.

  2007influential citation
• Function and molecular mechanisms of neuroendocrine cells in prostate cancer.

  2007cites this paper
• A New Binding Motif for the Transcriptional Repressor REST Uncovers Large Gene Networks Devoted to Neuronal Functions

  2007cites this paper
• Recombinant Human IFN-β Affects Androgen Receptor Level, Neuroendocrine Differentiation, Cell Adhesion, and Motility in Prostate Cancer Cells

  2007cites this paper
• Targeted Elimination of PCDH-PC Expressing Prostate Cancer Cells for Control of Hormone-Resistant Prostate Cancer

  2007cites this paper